Search
forResearch 10 of 702
- Distinguishing Mouse Strains by Proteomic Analysis of Pelage Hair
- Ficoll density gradient sedimentation isolation of pelage hair follicle mesenchymal stem cells from adult mouse back skin: a novel method for hair follicle mesenchymal stem cells isolation
- Ficoll density gradient sedimentation isolation of pelage hair follicle mesenchymal stem cells from adult mouse back skin: A novel methods for hair follicle mesenchymal stem cells isolation.
- Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin
- Cross‐linked features of mouse pelage hair resistant to detergent extraction
- Cross-linked features of mouse pelage hair resistant to detergent extraction
- Properties of Murine Pelage Hair Follicles in Monolayer and Collagen Matrix Cultures
- Expression of Cyclooxygenase Isozymes During Morphogenesis and Cycling of Pelage Hair Follicles in Mouse Skin: Precocious Onset of the First Catagen Phase and Alopecia upon Cyclooxygenase-2 Overexpression
- Effects of <i>in utero</i> retinoic acid exposure on mouse pelage hair follicle development
- Spatiotemporal secondary hair follicle development in the Lanyu pig (Sus scrofa taivanus): a novel pelage hair follicle model
Community 10 of 61
- Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy
- Pelage curing hair loss with PP405 could become one of the most famous discoveries in history
- Pelage PP405: New Hair Growth from Inactive Follicular Units - Phase 2a results at AAD 2026
- Will Pelage include Norwood 7 hair loss in PP405 phase 3 trials to see its true regenerative potential?
- New Study: PP405, developed by Pelage Pharmaceuticals, can reactivate dormant hair follicle stem cells and stimulate natural hair growth by 20%
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- Quote from Pelage (PP-405) Spokesperson...
- When do we hear about Pelage February 2025 study results?
- Pelage to present PP405 Phase 2a clinical trial full results at an upcoming medical meeting - CMO Christina Weng says
- Pelage, PP405, is creating a database for potential new trial volunteers